Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 3/20 | 0.46 |
| ▸ | TAS1R1 | Q7RTX1 | 3/20 | 0.46 |
| ▸ | TAS1R2 | Q8TE23 | 3/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.37 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | FPR1 | P21462 | 1/20 | 0.33 |
| ▸ | FPR2 | P25090 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13951088 | 0.91 | ALDH1A1 (0.45) | TAS1R3TAS1R1TAS1R2FOLH1NAALAD2 | |
| SCHEMBL21568355 | 0.85 | TAS1R3 (0.42) | TAS1R3TAS1R1TAS1R2ALDH1A1SMN1; SMN2 | |
| SCHEMBL23643076 | 0.81 | TAS1R3 (0.39) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL18793674 | 0.79 | POLB (0.45) | TAS1R3TAS1R1TAS1R2ALDH1A1MEN1 | |
| SCHEMBL22296593 | 0.79 | EPHX1 (0.39) | TAS1R3TAS1R1TAS1R2FOLH1NAALAD2 | |
| SCHEMBL24567754 | 0.79 | POLB (0.45) | TAS1R3TAS1R1TAS1R2ALDH1A1MEN1 | |
| SCHEMBL17533124 | 0.78 | — | — | |
| SCHEMBL4722756 | 0.78 | — | — | |
| SCHEMBL7883493 | 0.78 | — | — | |
| SCHEMBL4722759 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1279667-B1 | PROCESS FOR PRODUCING 1,3-DIALKYL-2-IMIDAZOLIDINONE COMPOUND | MITSUI CHEMICALS INC (JP) | 2010-10-27 | — | — | EP | disclosed |
| US-6861534-B2 | Process for producing 1,3-dialkyl-2-imidazolidinone compound | MITSUI CHEMICALS, INC. (JP) | 2005-03-01 | — | — | US | disclosed |
| EP-1279667-A1 | PROCESS FOR PRODUCING 1,3-DIALKYL-2-IMIDAZOLIDINONE COMPOUND | Mitsui Chemicals, Inc. (JP) | 2003-01-29 | — | — | EP | disclosed |
| US-20030009035-A1 | Process for producing 1,3-dialkyl-2-imidazolidinone compound | MITSUI CHEMICALS, INC. (JP) | 2003-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030009035-A1 | Process for producing 1,3-dialkyl-2-imidazolidinone compound | PIGS, DEK, B2M | TAS1R3 2063/4885TAS1R1 1758/4885TAS1R2 1823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.